Eevia Health aktie (EEVIA) | Aktieanalyser - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Läs mer: Investera i räntebärande lån – Historisk årlig avkastning på 9,9 % (annons)

Analyser av Eevia Health

 Analysbevakning
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

Comment on Eevia receiving a grant of approx. SEK 2.7m and multiple orders totaling approx. SEK 2.0m - Analyst Group

Eevia Health Plc (”Eevia” or “the Company”) announced on Tuesday, March 19th, that the Company has received a grant of approx.

Analyst Group • 19 Mar 14:04

Eevia Health: Navigating a Challenging H2-23 Through Enhanced Efficiency - Analyst Group

Eevia Health Plc (publ) (”Eevia Health”, “Eevia” or “the Company”) concludes a transformative 2023, marked by a sharp decline in net sales d...

Analyst Group • 22 Feb 10:31

Analyst Group Comment on Eevia Health's Q4-Report

On February 14th, Eevia Health published the company’s quarterly report for Q4-23.

Analyst Group • 16 Feb 07:30

Eevia Health entering negotiations for a significant sales contract for 2025 with an option to extend until 2027 - Analyst Group

Eevia Health Plc (”Eevia” or the “Company”) announced on Friday, January 12th, that the Company has entered into negotiations with a Europea...

Analyst Group • 12 Jan 13:23

Analyst Group Comment on Eevia’s reorganized distribution in North America and New Order

Eevia Health Plc's ("Eevia" or "the Company") announced on the 10th of January 2024 that the Company has reorganized distribution in North A...

Analyst Group • 11 Jan 07:26

Eevia Health: Transformative Journey to Diversify the Customer Base - Analyst Group

Eevia Health Plc (publ) (”Eevia Health”, “Eevia” or “the Company”) has entered into a transformational phase, with a clear focus on diversif...

Analyst Group • 20 Dec 2023 12:42

Analyst Group's Comment on Eevia Health’s Q3-report

On November 22nd, Eevia Health published the company’s quarterly report for Q3-23.

Analyst Group • 22 Nov 2023 14:13

Eevia Health: Record-Level Margins Generate Substantial Bottom-Line Profits - Analyst Group

Eevia Health Plc (publ) (”Eevia Health”, “Eevia” or “the Company”) is at a stage where the Company is scaling up the production capacity, fo...

Analyst Group • 20 Sep 2023 12:01

Analyst Group Comment on Eevia Health’s Q2-23 Report

On August 23rd, Eevia Health published the company’s quarterly report for Q2-23.

Analyst Group • 23 Aug 2023 16:06

Eevia Health: Improved Profitability and Strong Business Outlook - Analyst Group

Eevia Health Plc (publ) (”Eevia Health”, “Eevia” or “the Company”) is at a stage where the Company is scaling up the production capacity, fo...

Analyst Group • 20 Jun 2023 15:59

Analyst Group comment on Eevia Health’s Q1-23 Report

On May 16th, Eevia Health published the company’s quarterly report for Q1-23.

Analyst Group • 19 May 2023 07:29

Eevia Health: Getting Closer to Black Numbers after Operating Improvements - Analyst Group

Eevia Health Plc (publ) (”Eevia Health”, “Eevia” or “the Company”) is at a stage where the Company is scaling up the production capacity, fo...

Analyst Group • 22 Mar 2023 14:01

Analyst Group comment on Eevia Health’s Q4-22 Report

On February 24th, Eevia Health published the company’s quarterly report for Q4-22.

Analyst Group • 01 Mar 2023 13:32

Eevia Health: Comment on Q3-22 Report - Analyst Group

On the November 25th, Eevia Health (“Eevia” or “The company”) released its quarterly report for Q3-22.

Analyst Group • 30 Nov 2022 13:07

Eevia Health launches a new dietary supplement ingredient, Feno-Cerasus™ for cognitive health - Analyst Group

The 3rd of November, Eevia Health (“Eevia” or “the company”) announced that the company has developed a new plant extract with product benef...

Analyst Group • 10 Nov 2022 16:41

Analyst Group comments on Eevia Health receiving a New Sales Order for Elderberry Extracts Worth up to SEK 34.4m

Following a successful exhibition at the Supply Side West trade show in Las Vegas, US, last week, Eevia Health (”Eevia” or ”the company”) re...

Analyst Group • 09 Nov 2022 12:11

Analyst Group comments on Eevia Health Receiving Several Sales Orders for Bilberry Extracts Worth up to EUR 200k

The 18th of October, and on the 19th of October, Eevia Health (“Eevia” or “the company”) the company has received sales orders for bilberry ...

Analyst Group • 20 Oct 2022 10:10

Eevia Health: Profitable Growth Ahead - Analyst Group

Eevia Health offer organic plant extracts for food nutraceuticals, drinks, and cosmetics under different brands.

Analyst Group • 22 Sep 2022 15:10

Analyst Group comment on Eevia Health’s Q2-22 Report

On the 29th of August, Eevia Health (“Eevia” or “The company”) released its quarterly report for Q2-22.

Analyst Group • 31 Aug 2022 10:50

Analyst Group Initiates Equity Research Coverage on Eevia Health

Our analyst summarizes the investment case: “Eevia Health offer organic plant extracts for food nutraceuticals, drinks, and cosmetics under ...

Analyst Group • 29 Jun 2022 08:48